The earnings call highlighted significant achievements, including a substantial increase in R&D revenue, improved gross margin, and a reduction in net loss. Additionally, there was positive feedback from U.K. operations and increased share price. However, concerns include a decline in cash position, outstanding notes payable, and the delay of other projects due to a focus on burns. Overall, the positive developments and strategic focus outweigh the challenges.
Company Guidance
During the third quarter 2024 earnings call for Spectral AI, key financial metrics highlighted included a 138% increase in research and development revenue to $8.2 million, driven by activity under the BARDA Project BioShield contract. The gross margin improved to 44.9% from 42.8% in the previous year, while general and administrative expenses decreased to $4.6 million, representing 55% of revenue. The company reported a narrowed net loss of $1.5 million, or $0.08 per share, compared to a $10.6 million loss in the third quarter of last year. Spectral AI reiterated its revenue guidance for 2024 at approximately $28 million, reflecting a 55% increase from 2023, supported by ongoing BARDA contracts and developments in their DeepView SnapShot M device.
Significant Increase in R&D Revenue
Research and development revenue for the third quarter rose by 138% to $8.2 million from $3.4 million in the third quarter of last year.
Improved Gross Margin
Gross margin improved to 44.9% from 42.8% in last year's third quarter, reflecting increased product development activity and a higher reimbursement rate under the BARDA PBS contract.
Reduction in Net Loss
Net loss narrowed to $1.5 million or $0.08 per share from a net loss of $10.6 million or $0.77 per share in the third quarter of last year.
Promising Developments in the U.K.
The company's devices in the U.K. have received positive feedback, with plans to expand their availability to Australia under a special access program.
Positive Market Reaction
Share price increased by 30% from about $0.93 a share to about $1.5 per share shortly after Dr. DiMaio became Chairman of the Board.
---
Spectral AI (MDAI) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
MDAI Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 06, 2024
$1.51
$1.34
-11.26%
Aug 12, 2024
$1.66
$1.50
-9.64%
May 07, 2024
$1.72
$1.73
+0.58%
Mar 27, 2024
$2.12
$2.13
+0.47%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Spectral AI (MDAI) report earnings?
Spectral AI (MDAI) is schdueled to report earning on Mar 26, 2025, TBA Not Confirmed.
What is Spectral AI (MDAI) earnings time?
Spectral AI (MDAI) earnings time is at Mar 26, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.